Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation
Molecules · 11.12.2025 · 30 (24) · 4733
DOI: 10.3390/molecules30244733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.12.2025. Verfasst von Joanna Harasym und 2 weiteren Autor:innen. Beteiligte Einrichtung: Adaptive Food Systems Accelerator-Science Centre, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wroclaw, Poland. Hauptthemen laut MEDLINE: Tannins, Phaeophyceae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw University of Economics and Business, Wroclaw University of Economics and Business internal project Open Science.
Abstract (Originalsprache)
Phlorotannins, a unique group of polyphenolic compounds derived exclusively from brown macroalgae (Phaeophyceae), have gained substantial scientific and industrial interest due to their structural diversity and multifaceted bioactivities. These marine metabolites, composed of phloroglucinol units linked through various C–C and C–O–C bonds, exhibit broad-spectrum antioxidant, anti-inflammatory, antimicrobial, antidiabetic, anticancer, and neuroprotective effects. Despite their promising in vitro efficacy, large-scale application remains hindered by three critical translational barriers: (i) extreme natural variability in phlorotannin content driven by ecological and seasonal factors, complicating raw material standardization; (ii) physicochemical instability and poor aqueous solubility resulting in limited oral bioavailability; and (iii) insufficient development of advanced delivery systems to ensure controlled release and targeted bioactivity. This comprehensive review integrates ecological, biochemical, and technological perspectives to establish a unified framework for translating phlorotannin research toward clinical and commercial realization. It systematically examines biosynthetic regulation, structural classification, extraction and purification methods, bioactivity mechanisms, pharmacokinetic barriers, and toxicological safety considerations. The review concludes by highlighting future research priorities essential for achieving industrial scalability, formulation reproducibility, and regulatory acceptance in marine bioactive development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adaptive Food Systems Accelerator-Science Centre, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wroclaw, Poland.
- Department of Biotechnology and Food Analysis, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wroclaw, Poland.
ORCID-Profile: Joanna Harasym, Patryk Słota, Ewa Pejcz
Förderung
- Wroclaw University of Economics and Business
- Wroclaw University of Economics and Business internal project Open Science
Zitieren
APA
Harasym, J., Słota, P., & Pejcz, E. (2025). Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation. Molecules, 30(24), 4733. https://doi.org/10.3390/molecules30244733
Vancouver
Harasym J, Słota P, Pejcz E. Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation. Molecules. 2025;30(24):4733. doi:10.3390/molecules30244733
BibTeX
@article{Harasym2025,
author = {Harasym, Joanna and Słota, Patryk and Pejcz, Ewa},
title = {Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation},
journal = {Molecules},
year = {2025},
volume = {30},
number = {24},
pages = {4733},
doi = {10.3390/molecules30244733}
}
EUVIMED